FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine. Disclosed is a method of producing an antioxidant agent in the form of prolonged release, characterized in that a sifted mixture of ethyl methylhydroxypyridine succinate and hydroxypropyl methyl cellulose with viscosity of 2,700–5,040 MPa⋅with is mixed with a previously obtained moistening agent, which is an aqueous solution of hydroxypropyl methyl cellulose with viscosity of 4.8–7.2 mPa⋅s, the mixture is granulated in boiling (fluidized) layer; obtained granules are powdered with magnesium stearate and silicon with colloidal dioxide, subjected to dry granulation with subsequent pressing into tablets and film coating.
EFFECT: tablets have an improved pharmacological release profile.
4 cl, 1 tbl, 2 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 | 
 | RU2749718C1 | 
| PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 | 
 | RU2798106C1 | 
| PHARMACEUTICAL COMPOSITION IN THE FORM OF A COATED TABLET | 2022 | 
 | RU2786073C1 | 
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 | 
 | RU2530558C2 | 
| PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 | 
 | RU2444359C1 | 
| METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION HAVING NEUROPROTECTIVE ACTIVITY IN CHRONIC CEREBRAL ISCHEMIA | 2023 | 
 | RU2816359C1 | 
| COMPOSITION FOR TREATING DISTURBED INNERVATION (VERSIONS) | 2013 | 
 | RU2536269C1 | 
| PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, AND ALSO A DOSAGE FORM BASED ON SPECIFIED PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, METHOD OF ITS OBTAINING AND USE OF DOSAGE FORM BASED ON PHARMACEUTICAL CEUTIC COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE | 2020 | 
 | RU2810575C1 | 
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 | 
 | RU2611194C2 | 
| SYSTEM FOR DELIVERY OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION IN FORM OF GASTRORETENTIVE TABLET | 2019 | 
 | RU2734970C1 | 
Authors
Dates
2020-01-29—Published
2019-06-04—Filed